首页> 外文期刊>Korean Circulation Journal >Nitric Oxide Synthase Inhibition Attenuates Cardiac Response to Hemodilution with Viscogenic Plasma Expander
【24h】

Nitric Oxide Synthase Inhibition Attenuates Cardiac Response to Hemodilution with Viscogenic Plasma Expander

机译:一氧化氮合酶抑制作用减弱与黏性血浆扩展剂对血液稀释的心脏反应。

获取原文
       

摘要

Background and Objectives Increased vascular wall shear stress by elevated plasma viscosity significantly enhances the endothelial nitric oxide synthase (eNOS) activity during an acute isovolemic hemodilution. Also the modulation of plasma viscosity has effects on the cardiac function that were revealed if a left ventricular (LV) pressure-volume (PV) measurement was used. The aim of this study was to assess cardiac function responses to nitric oxide synthase (NOS) inhibitors with the presence of an elevated plasma viscosity but a low hematocrit level. Furthermore, systemic parameters were monitored in a murine model. Materials and Methods As test group five anesthetized hamsters were administered with N(G)-nitro-L-arginine methyl ester (L-NAME), NOS inhibitor, whereas five other hamsters were used as control group without L-NAME infusion. The dosage of L-NAME was 10 mg/kg. An isovolemic hemodilution was performed by 40% of estimated blood volume with 6% w/v dextran 2000 kDa, high viscosity plasma expanders (PEs) with viscosity 6.34 cP. LV function was measured and assessed using a 1.4 Fr PV conductance catheter. Results The study results demonstrated that NOS inhibition prevented the normal cardiac adaptive response after hemodilution. The endsystolic pressure increased 14% after L-NAME infusion and maintained higher than at the baseline after hemodilution, whereas it gradually decreased in the animals without L-NAME infusion. The admission of L-NAME significantly decreased the maximum rate of ventricular pressure rise (+dP/dtmax), stroke volume and cardiac output after hemodilution if compared to the control group (p Conclusion This finding supports the presumption that nitric oxide induced by an increased plasma viscosity with the use of a high viscosity PE plays a major role in the cardiac function during an acute isovolemic hemodilution.
机译:背景和目的在急性等容血液稀释过程中,血浆粘度升高会增加血管壁切应力,从而显着增强内皮型一氧化氮合酶(eNOS)的活性。如果使用左心室(LV)压力体积(PV)测量,血浆粘度的调制也会对心功能产生影响。这项研究的目的是评估血浆粘度升高但血细胞比容水平较低时对一氧化氮合酶(NOS)抑制剂的心脏功能反应。此外,在鼠模型中监测全身参数。材料和方法作为试验组,给五只麻醉的仓鼠施用N(G)-硝基-L-精氨酸甲酯(L-NAME),NOS抑制剂,而其他五只仓鼠用作对照组,不输注L-NAME。 L-NAME的剂量为10mg / kg。用估计的血液体积的40%和6%w / v 2000 kDa右旋糖酐,粘度为6.34 cP的高粘度血浆膨胀剂(PEs)进行等容血液稀释。使用1.4 Fr PV电导导管测量和评估LV功能。结果研究结果表明,NOS抑制可阻止血液稀释后正常的心脏适应性反应。 L-NAME输注后的收缩压升高了14%,并且在血液稀释后维持高于基线,而在没有L-NAME输注的动物中,收缩压逐渐降低。与对照组相比,L-NAME的使用显着降低了血液稀释后的最大心室压力上升率(+ dP / dt max ),中风量和心输出量(p结论)这一发现支持了推测在高等渗血液稀释过程中,血浆粘度增加引起的一氧化氮在心功能中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号